Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score -7.20
- Piotroski Score 4.00
- Grade Buy
- Symbol (ICCM)
- Company IceCure Medical Ltd
- Price $0.61
- Changes Percentage (-2.35%)
- Change -$0.01
- Day Low $0.61
- Day High $0.62
- Year High $1.57
IceCure Medical Ltd, a medical device company, engages in the research, development, and commercialization of medical devices for cryoablation (freezing) of tumors in the human body. It offers ProSense system, a cryoablation solution for the treatment of breast tumors. The company was incorporated in 2006 and is headquartered in Caesarea, Israel.
- Last Earnings
- Ex-Dividend for 5/16 Dividend
- Dividend Payable
- Today N/A
- Next Earnings (Estimated) 11/19/2024
- Fiscal Year End N/A
- Average Stock Price Target $5.75
- High Stock Price Target $5.75
- Low Stock Price Target $5.75
- Potential Upside/Downside N/A
- Consensus Rating Strong Sell
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) -$0.32
- Trailing P/E Ratio -2.37
- Forward P/E Ratio -2.37
- P/E Growth -2.37
- Net Income $-14,652,000
Income Statement
Quarterly
Annual
Latest News of ICCM
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
-
We're Keeping An Eye On IceCure Medical's (NASDAQ:ICCM) Cash Burn Rate
Investors are attracted to unprofitable companies due to potential growth. Analyzing IceCure Medical's cash burn and runway, it seems the company needs to manage its finances well to avoid distress. D...
By Yahoo! Finance | 3 months ago